Jared Kaltwasser

An open-label randomized trial found patients using the closed-loop system had more time in their target glucose ranges.

The study showed children with thalassemia had a greater risk of both atopic and non-atopic asthma.

Five gene hubs were identified, with one in particular appearing to correlate strongly with the pathogenesis of lupus nephritis.

The case required significant testing to get to the correct diagnosis, but the investigators hope their experience helps inform doctors facing similar cases in the future.

The report, based on a survey conducted in Spain, suggests patients are suffering from additional asthma exacerbations due to a lack of understanding of their disease.

A new sub-analysis suggested eating foods with anti-inflammatory properties may improve physical functioning in patients with rheumatoid arthritis.

A re-evaluation of patients found most had intermediate lupus erythematosus, even though the vast majority were initially diagnosed with the limited-cutaneous form of the disease.

In both blood and urine samples, patients with systemic lupus erythematosus and renal involvement were found to have higher levels of interleukin-35 compared with patients with systemic lupus erythematosus and no known renal involvement.

Lower indirect costs and a lower incidence of serious complications offset the higher cost of the advanced hybrid closed-loop insulin system.

As many as 4% of population-level asthma cases could be attributed to secondhand smoke, the study suggests.

The report suggests childcare concerns could be a significant factor keeping Black women from attending weekly workshops.

The analysis showed biomarkers that persisted despite the presence or absence of type-2 inflammation.

The parameter could potentially help clinicians zero in on the cause of left ventricular hypertrophy.

Patients with lupus nephritis (LN) were found to have as much as twice the inpatient hospitalizations of patients with systemic lupus erythematosus without LN.

A study suggests tumor in situ fluid is a better choice when trying to extract tumor DNA in patients with glioma who underwent surgery.

Cost increases were particularly pronounced among patients with severe systemic lupus erythematosus (SLE), the study found.

New data show the therapy led to minimal changes in renal function, even after more than 8 years.

Patients treated with immune checkpoint inhibitors had significantly different survival rates based on the test, regardless of PD ligand 1 classification.

The analysis found 20% of people with asthma, emphysema, or chronic bronchitis also have depression.

A new analysis suggests physicians should be on the lookout for cardiovascular disease and other types of cancer, in addition to acute myeloid lymphom, when caring for patients with certain myeloproliferative neoplasms (MPNs).

A new review article highlights some of the newest therapies available to treat graft-versus-host disease (GVHD), but the authors say there is insufficient data to draw broad conclusions.

In patients refractory to conventional therapy, the combination resulted in a 70% reduction in a key biomarker compared with placebo.

The report suggests factors besides molecular profiling can be helpful in patient stratification.

Twenty combinations of toxic pollutants were identified by a machine learning algorithm as being tied with asthma outcomes.

A new opinion piece makes the case that rheumatoid arthritis care can, and should, be better tailored to individual case characteristics.

The data suggest early factors in the home are the most important links to asthma risk in children.

An analysis of the latest research finds a robust approach to understanding particular prostate cancers remains necessary to finding optimal treatment.

Results of a pooled analysis showed patients with rheumatoid arthritis who take upadacitinib may be at increased risk of herpes zoster.

Patients with asthma have high rates of type 2 inflammatory disease, study finds.

New modeling could help explain why some patients develop resistance to tyrosine kinase inhibitors.